MiR-184, as well as β-catenin, TCF4, and c-MYC, which are downstream Wnt signaling pathway factors, is negatively impacted by MEG3, which inhibits the replication and the migration of osteosarcoma cells in vitro and cancerous growth in vivo (127). This evidence concerns the gene MEG3 and osteosarcoma.